KARO HEALTHCARE NORGE AS
Operating
Utvikling, produksjon og salg av legemidler og andre helseprodukter og
alle aktiviteter knyttet hertil, på egen hånd eller gjennom eierskap i
andre selskaper.
Produksjon og salg av legemidler
Links
Organization
- CEO
- ET
Esad Toric1985
- Chairman of the board
- Years since formation
- 24 years
- since Oct 2, 2001
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 36,472,069
- 1 share class
- Total number of shareholders
- 1
- person
- Belongs to group of
Financials
- Annual total result 2024
- 99,241,571
- NOK
- Total equity 2024
- 1,643,445,788
- NOK
Last update: Sep 9, 2025
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
ET 1985 | Managing Director/CEO | - |
Board
| Name | Role | Shares |
|---|---|---|
| Chairman | - | |
EM | Board Member | - |
| Board Member | - |
Others
| Name | Role | Shares |
|---|---|---|
| Auditor | - | |
| Accountant | - |
Last update: Feb 24, 2025
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| NO0010308240 | 36,472,069 | 100 % |
Shares owned by the KARO HEALTHCARE NORGE AS
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 6,798,000 | 100 % |
Last update: Jun 2, 2025
Group structure
- Total operating income 2024: NOK 0Operating profit 2024: NOK -345,966Employees: 0
Financials
in NOK
Summary
| Year | 2024 | 2023 | 2022 |
|---|---|---|---|
Total operating income | 0 | 0 | 0 |
Annual Total Result | 99,241,571 | 122,607,327 | 99,387,774 |
Total assets | 1,643,620,491 | 1,544,254,241 | 1,446,898,749 |
Total liabilities | 174,703 | 50,025 | 25,301,859 |
Total equity | 1,643,445,788 | 1,544,204,217 | 1,421,596,890 |
P&L
| Year | 2024 | 2023 | 2022 |
|---|---|---|---|
Total operating income | 0 | 0 | 0 |
Total operating costs | 345,966 | 311,402 | 166,726 |
Operating result | -345,966 | -311,402 | -166,726 |
Financial income/costs | 127,578,749 | 157,500,283 | 127,586,949 |
Profit before tax | 127,232,783 | 157,188,881 | 127,420,223 |
Total tax & extraordinary income/cost | 27,991,212 | 34,581,554 | 28,032,449 |
Annual Total Result | 99,241,571 | 122,607,327 | 99,387,774 |
Balance overview
| Year | 2024 | 2023 | 2022 |
|---|---|---|---|
Total fixed assets | 1,252,412,083 | 1,280,403,295 | 1,314,984,849 |
Total current assets | 391,208,408 | 263,850,947 | 131,913,900 |
Total assets | 1,643,620,491 | 1,544,254,241 | 1,446,898,749 |
Short term debt | 174,703 | 50,025 | 25,301,859 |
Long term debt | 0 | 0 | 0 |
Total liabilities | 174,703 | 50,025 | 25,301,859 |
Contributed capital | 1,045,149,871 | 1,045,149,871 | 1,045,149,871 |
Retained earnings | 598,295,917 | 499,054,345 | 376,447,019 |
Total equity | 1,643,445,788 | 1,544,204,217 | 1,421,596,890 |
Total equity and liabilities | 1,643,620,491 | 1,544,254,241 | 1,446,898,749 |
Classification
21st company classification
BETA
Individual SMB enterprise
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises